In the present study, we suggest that the LOX-1 expressed in tumor tissues was an independent prognostic factor for OS in GC patients, providing the additional evidence that LOX-1 expression can be a promising prognostic factor in different types of cancers. The gene discussed is OLR1; the disease is gastric cancer.